« Previous
Next »
Journal of Surgical Research
Volume 142, Issue 2
, Pages 233-238
, October 2007
A Comparative Analysis Between Survivors and Nonsurvivors with Antibody Mediated Cardiac Allograft Rejection
References
- Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant. 2003;22:58
- Vascular rejection in heart transplantation: Clinical correlation, treatment options, and future considerations. J Heart Lung Transplant. 1993;12:S135
- Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant. 1999;18:904
- Arteriolar vasculitis on endomyocardial biopsy: A histologic predictor of poor outcome in cyclosporine-treated heart transplant recipients. J Heart Transplant. 1987;6:127
- Vascular (humoral) rejection in heart transplantation: Pathologic observations and clinical implications. J Heart Transplant. 1989;8:430
- Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24:1710
- Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant. 2006;25:153
- Quantitative flow cytometry cross-matching for precise measurement of donor-specific alloreactivity. Transplant Proc. 1994;26:2866
- Immunofluorescence of endomyocardial biopsy specimens: Methods and interpretation. J Heart Lung Transplant. 1993;12:S113
- Allograft coronary artery disease: Clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection. J Heart Lung Transplant. 2000;19:518
- Vascular rejection in heart transplant recipients. J Heart Lung Transplant. 1993;12:S147
- Virtual Cross-match allows the expansion of effective donor pool for HLA sensitized patients. J Heart Lung Transplant. 2006;25:140
- Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. Transplant Proc. 1993;25:262
- HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant. 2004;23:1135
- Vascular rejection of human cardiac allografts and the role of humoral immunity in chronic allograft rejection. Transplant Proc. 1991;23(2 Suppl 2):26
- Noncomplement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant. 2004;4:326
- Anti-idiotypic antibodies specific for HLA in heart and kidney allograft recipients. Immunol Res. 1993;12:1
- Vascular rejection and its relationship to allograft coronary artery disease. J Heart Lung Transplant. 1992;11:S111
- Role of humoral immunity in acute cardiac allograft dysfunction. J Heart Lung Transplant. 1993;12:S143
- Clinical-pathologic features of humoral rejection in cardiac allografts: A study in 81 consecutive patients. J Heart Lung Transplant. 1995;14:151
- Expression of complement-regulatory proteins in normal and UW-preserved human liver. Gastroenterology. 1994;107:505
- Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol. 2004;172:3869
- Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation. 1999;6:194
- Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med. 1995;1:423
PII: S0022-4804(07)00314-9
doi: 10.1016/j.jss.2007.04.023
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Surgical Research
Volume 142, Issue 2
, Pages 233-238
, October 2007
